blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1283704

EP1283704 - PHARMACEUTICAL COMPOSITIONS FOR TRANSDERMAL ADMINISTRATION OF ANTI-INFLAMMATORY AGENTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.10.2014
Database last updated on 14.06.2024
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): TR		published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
SANOFI
54, rue La Boétie
75008 Paris / FR
[2013/51]
Former [2012/18]For all designated states
SANOFI
54 rue La Boétie
75008 Paris / FR
Former [2012/17]For all designated states
SANOFI
54, rue de la Boétie
75008 Paris / FR
Former [2011/30]For all designated states
SANOFI
174, Avenue de France
75013 Paris / FR
Former [2004/44]For all designated states
Sanofi-Aventis
174, Avenue de France
75013 Paris / FR
Former [2003/08]For all designated states
SANOFI-SYNTHELABO
174, Avenue de France
75013 Paris / FR
Inventor(s)01 / ILLEL, Brigitte
91, rue René Clair
F-34070 Montpellier / FR
02 / VERGNAUD, Jean-Pierre
292, rue du Lavandin
F-34070 Montpellier / FR
 [2003/08]
Representative(s)Thouret-Lemaitre, Elisabeth, et al
Sanofi
Département Brevets
54, rue La Boétie
75008 Paris / FR
[2013/51]
Former [2003/08]Thouret-Lemaitre, Elisabeth, et al
Sanofi-Synthélabo Service Brevets 174, avenue de France
75013 Paris / FR
Application number, filing date01934105.611.05.2001
[2003/08]
WO2001FR01442
Priority number, dateFR2000000604812.05.2000         Original published format: FR 0006048
[2003/08]
Filing languageFR
Procedural languageFR
PublicationType: A2 Application without search report
No.:WO0185143
Date:15.11.2001
Language:FR
[2001/46]
Type: A2 Application without search report 
No.:EP1283704
Date:19.02.2003
Language:FR
The application published by WIPO in one of the EPO official languages on 15.11.2001 takes the place of the publication of the European patent application.
[2003/08]
Type: B1 Patent specification 
No.:EP1283704
Date:18.12.2013
Language:FR
[2013/51]
Search report(s)International search report - published on:EP10.05.2002
ClassificationIPC:A61K9/00, A61K31/192
[2013/27]
CPC:
A61K9/7015 (EP,US); A61K31/192 (EP,US); A61K9/0014 (EP,US);
A61P29/00 (EP)
Former IPC [2003/08]A61K9/70
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/08]
Extension statesAL12.12.2002
LT12.12.2002
LV12.12.2002
MK12.12.2002
RO12.12.2002
SI12.12.2002
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR TRANSDERMALEN VERABREICHUNG VON ENTZÜNDUNGSHEMMERN[2003/08]
English:PHARMACEUTICAL COMPOSITIONS FOR TRANSDERMAL ADMINISTRATION OF ANTI-INFLAMMATORY AGENTS[2003/08]
French:COMPOSITIONS PHARMACEUTIQUES POUR ADMINISTRATION TRANSDERMIQUE D' AGENTS ANTI-INFLAMMATOIRES[2003/08]
Entry into regional phase12.12.2002National basic fee paid 
12.12.2002Designation fee(s) paid 
12.12.2002Examination fee paid 
Examination procedure29.11.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
12.12.2002Examination requested  [2003/08]
16.12.2003Despatch of a communication from the examining division (Time limit: M06)
15.06.2004Reply to a communication from the examining division
30.12.2005Despatch of a communication from the examining division (Time limit: M06)
07.07.2006Reply to a communication from the examining division
21.07.2006Despatch of a communication from the examining division (Time limit: M06)
07.03.2007Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
30.04.2007Reply to a communication from the examining division
12.01.2009Despatch of a communication from the examining division (Time limit: M06)
17.07.2009Reply to a communication from the examining division
27.05.2013Cancellation of oral proceeding that was planned for 28.05.2013
28.05.2013Date of oral proceedings (cancelled)
08.07.2013Communication of intention to grant the patent
07.11.2013Fee for grant paid
07.11.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  16.12.2003
Opposition(s)19.09.2014No opposition filed within time limit [2014/48]
Request for further processing for:30.04.2007Request for further processing filed
02.05.2007Full payment received (date of receipt of payment)
Request granted
15.05.2007Decision despatched
Fees paidRenewal fee
13.05.2003Renewal fee patent year 03
13.05.2004Renewal fee patent year 04
12.05.2005Renewal fee patent year 05
10.05.2006Renewal fee patent year 06
14.05.2007Renewal fee patent year 07
28.03.2008Renewal fee patent year 08
02.06.2009Renewal fee patent year 09
31.03.2010Renewal fee patent year 10
11.05.2011Renewal fee patent year 11
08.03.2012Renewal fee patent year 12
10.05.2013Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT18.12.2013
CY18.12.2013
DK18.12.2013
ES18.12.2013
FI18.12.2013
IT18.12.2013
MC18.12.2013
NL18.12.2013
SE18.12.2013
TR18.12.2013
GR19.03.2014
PT18.04.2014
IE11.05.2014
LU11.05.2014
BE31.05.2014
CH31.05.2014
LI31.05.2014
[2016/33]
Former [2016/32]AT18.12.2013
CY18.12.2013
DK18.12.2013
ES18.12.2013
FI18.12.2013
IT18.12.2013
MC18.12.2013
NL18.12.2013
SE18.12.2013
GR19.03.2014
PT18.04.2014
IE11.05.2014
LU11.05.2014
BE31.05.2014
CH31.05.2014
LI31.05.2014
Former [2016/29]AT18.12.2013
CY18.12.2013
DK18.12.2013
ES18.12.2013
FI18.12.2013
IT18.12.2013
MC18.12.2013
NL18.12.2013
SE18.12.2013
GR19.03.2014
PT18.04.2014
IE11.05.2014
LU11.05.2014
CH31.05.2014
LI31.05.2014
Former [2016/28]AT18.12.2013
CY18.12.2013
DK18.12.2013
ES18.12.2013
FI18.12.2013
MC18.12.2013
NL18.12.2013
SE18.12.2013
GR19.03.2014
PT18.04.2014
IE11.05.2014
LU11.05.2014
CH31.05.2014
LI31.05.2014
Former [2015/21]AT18.12.2013
CY18.12.2013
DK18.12.2013
ES18.12.2013
FI18.12.2013
MC18.12.2013
NL18.12.2013
SE18.12.2013
PT18.04.2014
IE11.05.2014
LU11.05.2014
CH31.05.2014
LI31.05.2014
Former [2015/09]AT18.12.2013
CY18.12.2013
DK18.12.2013
ES18.12.2013
FI18.12.2013
MC18.12.2013
NL18.12.2013
SE18.12.2013
PT18.04.2014
LU11.05.2014
CH31.05.2014
LI31.05.2014
Former [2015/08]AT18.12.2013
CY18.12.2013
DK18.12.2013
ES18.12.2013
FI18.12.2013
NL18.12.2013
SE18.12.2013
PT18.04.2014
LU11.05.2014
CH31.05.2014
LI31.05.2014
Former [2015/04]AT18.12.2013
CY18.12.2013
DK18.12.2013
ES18.12.2013
FI18.12.2013
NL18.12.2013
SE18.12.2013
PT18.04.2014
LU11.05.2014
Former [2014/48]AT18.12.2013
CY18.12.2013
DK18.12.2013
ES18.12.2013
FI18.12.2013
NL18.12.2013
SE18.12.2013
PT18.04.2014
Former [2014/39]AT18.12.2013
CY18.12.2013
ES18.12.2013
FI18.12.2013
NL18.12.2013
SE18.12.2013
PT18.04.2014
Former [2014/37]AT18.12.2013
CY18.12.2013
ES18.12.2013
FI18.12.2013
SE18.12.2013
PT18.04.2014
Former [2014/22]FI18.12.2013
SE18.12.2013
Cited inInternational searchJPS59216822  [ ] (TERUMO CORP);
 [X]EP0450123  (SAGITTA ARZNEIMITTEL GMBH [DE]) [X] 1,4,6,7,11,12 * page 3, line 27 - line 37 * * page 4 - page 5; example 1 *;
 JPH04234314  [ ] (MIKASA SEIYAKU KK);
 [X]US5350769  (KASAI SHUICHI [JP], et al) [X] 1,2,4-6,14 * column 3; example 1 *;
 [DA]WO9630000  (SANOFI SA [FR], et al) [DA] 1-30 * the whole document *;
 [X]WO9939713  (CHONG KUN DANG CORP [KR], et al) [X] 1,4-6,9,11,12,17,18,22 * page 4, line 5 - line 27 * * page 13 - page 15; examples 3-6 *;
 [X]  - SAITO, HIROSHI ET AL, "Topical gel preparations containing absorption accelerators, and", CHEMABS, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 117:239871 HCA, URL: STN, XP002157095 [X] 1-4,6,7,11,12 * abstract *
 [X]  - TERUMO CORP., JAPAN, "Film -forming topical formulations", CHEMABS, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 102:137818 HCA, URL: STN, XP002157096 [X] 1,4,6,9 * abstract *
 [A]  - SANTUS G C ET AL, "TRANSDERMAL ENHANCER PATENT LITERATURE", JOURNAL OF CONTROLLED RELEASE,NL,ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, (19930527), vol. 25, no. 1 / 02, ISSN 0168-3659, pages 1 - 20, XP000361364 [A] 17-20 * the whole document *

DOI:   http://dx.doi.org/10.1016/0168-3659(93)90090-R
ExaminationWO9909954
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.